1. Report Overview
1.1 Global Vaccine Contract Manufacturing Market Overview
1.2 Overview of Findings
1.3 Structure of the Report
1.4 Global Vaccine Contract Manufacturing Market Segmentation
1.5 Why You Should Read This Report
1.6 How This Report Delivers
1.7 Key Questions Answered by This Analytical Report
1.8. Who is This Report For?
1.9 Methodology
1.10 Associated Visiongain Reports
1.11 About Visiongain
2. Introduction to Vaccines
2.1 The History of Vaccines
2.2 How Do Vaccines Work?
2.3 Types of Vaccine
2.3.1 Attenuated Vaccine
2.3.2 Inactivated Vaccine
2.3.2 Inactivated Vaccine
2.3.4. Subunit Vaccines
2.3.4.1. Recombinant Subunit Vaccines
2.3.4.1. Recombinant Subunit Vaccines
2.3.4.1. Recombinant Subunit Vaccines
2.3.7 Therapeutic Vaccines
2.4 The Rise of the Vaccines Market
2.5 Technological and Regulatory Improvements
2.6 Vaccine Manufacturing Technologies
2.7 New Substrates for Vaccine Production
2.7.1 Shift towards Cell-Based Manufacturing Technology
2.7.2 Benefits of Cell-Based Techniques
2.8 Drivers
2.8.1 Global increase in vaccination coverage
2.8.2 Cost and time saving benefits offered by contract services
2.9 Restraint
2.9.1 Limited outsourcing by well-established vaccine manufacturers
2.9.2. Other restrains
3. Vaccine Contract Manufacturing Market, 2020-2030
3.1 The Global Vaccine Contract Manufacturing Market: Market Overview
3.2 Outsourcing in the Pharmaceutical and Biotechnology Industry
3.3 Global Vaccine Contract Manufacturing Market: Revenue Forecast 2020-2030
3.4 Global Vaccine Contract Manufacturing Market: Market Forecast 2020-2030
3.5 Changing Market Shares by Segment 2020-2030
3.6 Attenuated Vaccine: Revenue Forecast, 2018-2030
3.7 Inactivated Vaccine: Revenue Forecast, 2018-2030
3.8 Fluoroquinolones: Revenue Forecast 2018-2030
3.9 Subunit Vaccines: Revenue Forecast 2018-2030
3.10 Toxoid Vaccines: Revenue Forecast 2018-2030
3.11 Others: Revenue Forecast 2018-2030
4. Vaccine Contract Manufacturing Market, by Workflow, 2020-2030
4.1 The Global Vaccine Contract Manufacturing Market: Market Overview
4.2 Global Vaccine Contract Manufacturing Market, By Workflow: Revenue Forecast 2020-2030
4.3 Changing Market Shares by Segment 2020-2030
4.4 Downstream Processing
4.4.1 Fill & Finish Operations: Revenue Forecast 2018-2030
4.4.2 Analytical & QC studies: Revenue Forecast, 2018-2030
4.4.3 Packaging: Revenue Forecast 2018-2030
4.5 Upstream Processing
4.5.1 Mammalian Expression Systems: Revenue Forecast 2018-2030
4.5.2 Bacterial Expression Systems: Revenue Forecast 2018-2030
4.5.3 Yeast Expression Systems: Revenue Forecast 2018-2030
4.5.4 Baculovirus/Insect Expression Systems: Revenue Forecast, 2018-2030
4.5.6 Others: Revenue Forecast, 2018-2030
5. Vaccine Contract Manufacturing Market, By Application, 2020-2030
5.1 The Global Vaccine Contract Manufacturing Market: Market Overview
5.2 Global Vaccine Contract Manufacturing Market: Revenue Forecast 2020-2030
5.3 Changing Market Shares by Segment 2020-2030
5.4 Paediatric Vaccines: Revenue Forecast, 2018-2030
5.5 Adult Vaccines: Revenue Forecast, 2018-2030
5.6 Influenza Vaccines: Revenue Forecast, 2018-2030
5.7 Therapeutic Vaccines: Revenue Forecast, 2018-2030
6. Leading National Markets 2020-2030
6.1. Geographical Breakdown of the World Vaccine Contract Manufacturing Market
6.2 World Vaccine Contract Manufacturing Market: Regional Forecast 2020-2030
6.2.1 How Will Regional Market Shares Change to 2030?
7. North America Vaccine Contract Manufacturing Market 2020-2030
7.1. North America Vaccine Contract Manufacturing Market: Market Forecast, By Vaccine Type 2020-2030
7.2. North America Vaccine Contract Manufacturing Market: Market Forecast, By Workflow 2020-2030
7.3. US Vaccine Contract Manufacturing Market: Market Forecast 2020-2030
7.4. Canada Vaccine Contract Manufacturing Market: Trends and Developments
8. Europe Vaccine Contract Manufacturing Market 2020-2030
8.1. Europe Vaccine Contract Manufacturing Market: Market Forecast, By Vaccine Type 2020-2030
8.2. Europe Vaccine Contract Manufacturing Market: Market Forecast, By Workflow 2020-2030
8.3 Europe Markets: Changing Market Shares by Country, 2020-2030
8.4. Germany Vaccine Contract Manufacturing Market: Market Forecast 2020-2030
8.5. France Vaccine Contract Manufacturing Market: Trends and Developments
8.6. U.K. Vaccine Contract Manufacturing Market: Market Forecast 2020-2030
8.7. Italy Vaccine Contract Manufacturing Market: Trends and Developments
8.8. Spain Vaccine Contract Manufacturing Market: Market Forecast 2020-2030
8.9. Rest of Europe Vaccine Contract Manufacturing Market: Market Forecast 2020-2030
9. Asia Pacific Vaccine Contract Manufacturing Market 2020-2030
9.1. Asia Pacific Vaccine Contract Manufacturing Market: Market Forecast, By Vaccine Type 2020-2030
9.2. Asia Pacific Vaccine Contract Manufacturing Market: Market Forecast, By Workflow 2020-2030
9.3. Japan Vaccine Contract Manufacturing Market: Market Forecast 2020-2030
9.4. China Vaccine Contract Manufacturing Market: Market Forecast 2020-2030
9.5. India Vaccine Contract Manufacturing Market: Market Forecast 2020-2030
9.6. Rest of Asia Pacific Vaccine Contract Manufacturing Market: Trends and Developments
10. Latin America Vaccine Contract Manufacturing Market 2020-2030
10.1. Latin America Vaccine Contract Manufacturing Market: Market Forecast, By Vaccine Type 2020-2030
10.2. Latin America Vaccine Contract Manufacturing Market: Market Forecast, By Workflow 2020-2030
10.3. Brazil Vaccine Contract Manufacturing Market: Market Forecast 2020-2030
10.4. Mexico Vaccine Contract Manufacturing Market: Trends and Developments
10.5. Rest of Latin America Vaccine Contract Manufacturing Market: Trends and Developments
11. Middle East & Africa Vaccine Contract Manufacturing Market 2020-2030
11.1. Middle East & Africa Vaccine Contract Manufacturing Market: Market Forecast, By Vaccine Type 2020-2030
11.2. Middle East & Africa Vaccine Contract Manufacturing Market: Market Forecast, By Workflow 2020-2030
11.3. Saudi Arabia Vaccine Contract Manufacturing Market: Market Forecast 2020-2030
11.4. South Africa Vaccine Contract Manufacturing Market: Trends and Developments
11.5. Rest of Middle East & Africa Vaccine Contract Manufacturing Market: Trends and Developments
12. Leading Companies in the Vaccine Contract Manufacturing Market, 2020
12.1 LONZA
12.1.1 Overview
12.1.2 Lonza: Products and Services Offered
12.1.3 Lonza: Financial Overview
12.1.4 Recent Transactions Summary
12.2 Pfizer, Inc.
12.2.1 Overview
12.2.2 Pfizer: Products and Services Offered
12.2.3 Pfizer, Inc.: Financial Overview
12.2.4 Recent Transactions Summary
12.3 Merck & Co., Inc.
12.3.1 Overview
12.3.2 Merck & Co., Inc.: Products and Services Offered
12.3.3 Merck & Co., Inc..: Financial Overview
12.3.4 Recent Transactions Summary
12.4 AbbVie
12.4.1 Overview
12.4.2 AbbVie: Vaccine Contract Manufacturing Product/Services Portfolio
12.4.3 AbbVie: Financial Overview
12.4.4 AbbVie: Recent Transactions Summary
12.5 Baxter (Baxter BioPharma Solutions)
12.5.1 Overview
12.5.2 Baxter: Vaccine Contract Manufacturing Product/Services Portfolio
12.5.3 Baxter: Financial Overview
12.5.4 Recent Transactions Summary
12.6 Catalent, Inc.
12.6.1 Overview
12.6.2 Catalent, Inc.: Vaccine Contract Manufacturing Product/Services Portfolio
12.6.3 Catalent, Inc.: Financial Overview
12.6.4 Recent Transactions Summary
12.7 PRA Health Sciences
12.7.1 Overview
12.7.2 PRA Health Sciences, Inc.: Vaccine Contract Manufacturing Product/Services Portfolio
12.7.3 PRA Health Sciences, Inc.: Financial Overview
12.7.4 Recent Transactions Summary
12.8 KBI Biopharma, Inc.
12.8.1 Overview
12.8.2 KBI Biopharma, Inc.: Vaccine Contract Manufacturing Product/Services Portfolio
12.8.3 Recent Transactions Summary
12.9 Charles River Laboratories
12.9.1 Overview
12.9.2 Charles River Laboratories: Vaccine Contract Manufacturing Product/Services Portfolio
12.9.3 Charles River Laboratories: Financial Overview
12.9.4 Recent Transactions Summary
12.10 Boehringer Ingelheim
12.10.1 Overview
12.10.2 Boehringer Ingelheim: Vaccine Contract Manufacturing Product/Services Portfolio
12.10.3 Boehringer Ingelheim: Financial Overview
12.10.4 Recent Transactions Summary
12.11 IDT Biologika GmbH
12.11.1 Overview
12.11.2 IDT Biologika GmbH: Vaccine Contract Manufacturing Product/Services Portfolio
12.11.3 Recent Transactions Summary
12.12 Meridian Life Science
12.12.1 Overview
12.12.2 Meridian Life Science: Vaccine Contract Manufacturing Product/Services Portfolio
12.12.3 Meridian Life Science: Financial Overview
12.12.4 Recent Transactions Summary
13. Qualitative Analysis of the Vaccine Contract Manufacturing Market, 2020-2030
13.1. Vaccine Contract Manufacturing Industry Trends
13.2 Strengths and Weaknesses of the Vaccine Contract Manufacturing Market, 2020
13.2.1 Strengths
13.2.1.1 Cost of in-house capabilities
13.2.1.2 Outsourcing Improves Time to Market
13.2.1.3 Manufacturers Get Access to Specialised Technologies
13.2.1.3 Manufacturers Get Access to Specialised Technologies
13.2.2 Weaknesses
13.2.2.1 Mass Vaccine Manufacturing Kept In-house
13.2.2.2. A Highly-Fragmented Vaccine Contract Manufacturing Market
13.2.3. Opportunities
13.2.3.1 Many Vaccines in the Product Pipeline
13.2.3.2 Emerging Market’s Growing Demand for Vaccines
13.2.3.3 Dynamic Change: Emerging Markets are Major Vaccine Developers
13.1.3.4. Changing World Demographics
13.2.4. Threats
13.2.4.1 Post Recession: Biotech Suffer from Severe Cuts in Capital Funding
13.2.4.2 The Public are Slow to Accept Novel Technologies
13.2.4.3 Perception of Risk by the Original Vaccine Manufacturers
13.3 Vaccine Contract Manufacturing Drivers and Restraints, 2020-2030
14. Conclusions
14.1 Overview of Current Market Conditions and Market Forecast, 2020-2030
14.2 Attenuated Vaccine Will Remain the Dominant Vaccine Type
14.3 Leading Regions in the Vaccine Contract Manufacturing Market in 2018
14.4 Trends in the Vaccine Contract Manufacturing Market
Glossary
Associated Visiongain Reports
Visiongain Report Sales Order Form
About Visiongain
Visiongain report evaluation form
List of Figures
Figure 1.1 Global Vaccine Contract Manufacturing Market Segmentation Overview
Figure 3.1 Vaccine Contract Manufacturing Market: Market Share (%) by Vaccine Type, 2019
Figure 3.2 Vaccine Contract Manufacturing Market: Market Share (%) by Class, 2020
Figure 3.3 Global Vaccine Contract Manufacturing Market Forecast: Revenue ($ m), AGR (%), 2018-2030
Figure 3.4 The Global Vaccine Contract Manufacturing Market Forecast by Vaccine Type, 2018
Figure 3.5 The Global Vaccine Contract Manufacturing Market Forecast by Vaccine Type, 2019
Figure 3.6 The Global Vaccine Contract Manufacturing Market Forecast by Vaccine Type: CAGR (%), 2020-2030
Figure 3.7 The Vaccine Contract Manufacturing Market Segments: Revenue* ($m) Forecast, 2018-2030
Figure 3.8 Global Vaccine Contract Manufacturing Market by Vaccine Type: Market Share (%), 2018
Figure 3.9 Global Vaccine Contract Manufacturing Market by Vaccine Type: Market Share (%), 2024
Figure 3.10 Global Vaccine Contract Manufacturing Market by Vaccine Type: Market Share (%), 2030
Figure 3.11 Global Attenuated Vaccine Market Forecast: Revenue ($ m), AGR (%), 2018-2030
Figure 3.12 Global Inactivated Vaccine Market Forecast: Revenues ($m) AGR (%), AGR (%), 2020-2030
Figure 3.13 Global Fluoroquinolones Market Forecast: Revenues ($m) AGR (%), AGR (%), 2020-2030
Figure 3.14 Global Subunit Vaccines Market Forecast: Revenues ($m) AGR (%), AGR (%), 2020-2030
Figure 3.15 Global Toxoid Vaccines Market Forecast: Revenues ($m) AGR (%), AGR (%), 2020-2030
Figure 3.16 Others Drugs Market Forecast: Revenue ($ m), AGR (%), 2018-2030
Figure 4.1 Vaccine Contract Manufacturing Market: Market Share (%) by Workflow, 2019
Figure 4.2 Vaccine Contract Manufacturing Market: Market Share (%) by Class, 2020
Figure 4.3 The Global Vaccine Contract Manufacturing Market Forecast by Workflow, 2019
Figure 4.4 The Global Vaccine Contract Manufacturing Market Forecast by Workflow, 2020
Figure 4.5 The Global Vaccine Contract Manufacturing Market Forecast by Workflow: CAGR (%), 2020-2030
Figure 4.6 The Vaccine Contract Manufacturing Market Segments: Revenue* ($m) Forecast, 2018-2030
Figure 4.7 Global Vaccine Contract Manufacturing Market by Workflow: Market Share (%), 2019
Figure 4.8 Global Vaccine Contract Manufacturing Market by Workflow: Market Share (%), 2024
Figure 4.9 Global Vaccine Contract Manufacturing Market by Workflow: Market Share (%), 2030
Figure 4.10 Global Vaccine Contract Manufacturing (Downstream Processing) Market: Revenue* ($m) Forecasts by Segment,2018-2030
Figure 4.11 Global Vaccine Contract Manufacturing (Downstream Processing) Market: Market Share (%), 2019
Figure 4.12 Global Vaccine Contract Manufacturing (Downstream Processing) Market: Market Share (%), 2024
Figure 4.13 Global Vaccine Contract Manufacturing (Downstream Processing) Market: Market Share (%), 2030
Figure 4.14 Global Fill & Finish Operations Market Forecast: Revenue ($ m), AGR (%), 2018-2030
Figure 4.15 Global Analytical & QC studies Market Forecast: Revenue ($ m), AGR (%), 2018-2030
Figure 4.16 Global Packaging Market Forecast: Revenue ($ m), AGR (%), 2018-2030
Figure 4.17 Global Vaccine Contract Manufacturing (Upstream Processing) Market: Revenue* ($m) Forecasts by Segment,2018-2030
Figure 4.18 Global Vaccine Contract Manufacturing (Upstream Processing) Market: Market Share (%), 2019
Figure 4.19 Global Vaccine Contract Manufacturing (Upstream Processing) Market: Market Share (%), 2024
Figure 4.20 Global Vaccine Contract Manufacturing (Upstream Processing) Market: Market Share (%), 2030
Figure 4.21 Global Mammalian Expression Systems Market Forecast: Revenue ($ m), AGR (%), 2018-2030
Figure 4.22 Global Bacterial Expression Systems Market Forecast: Revenue ($ m), AGR (%), 2018-2030
Figure 4.23 Global Yeast Expression Systems Market Forecast: Revenue ($ m), AGR (%), 2018-2030
Figure 4.24 Global Baculovirus/Insect Expression Systems Market Forecast: Revenue ($ m), AGR (%), 2018-2030
Figure 4.25 Global Others Market Forecast: Revenue ($ m), AGR (%), 2018-2030
Figure 5.1 Vaccine Contract Manufacturing Market: Market Share (%) by Application, 2019
Figure 5.2 Vaccine Contract Manufacturing Market: Market Share (%) by Class, 2020
Figure 5.3 The Global Vaccine Contract Manufacturing Market Forecast by Application, 2018
Figure 5.4 The Global Vaccine Contract Manufacturing Market Forecast by Application, 2019
Figure 5.5 The Global Vaccine Contract Manufacturing Market Forecast by Application: CAGR (%), 2020-2030
Figure 5.6 The Vaccine Contract Manufacturing Market Segments: Revenue* ($m) Forecast, 2018-2030
Figure 5.7 Global Vaccine Contract Manufacturing Market by Application: Market Share (%), 2018
Figure 5.8 Global Vaccine Contract Manufacturing Market by Application: Market Share (%), 2024
Figure 5.9 Global Vaccine Contract Manufacturing Market by Application: Market Share (%), 2030
Figure 5.10 Global Paediatric Vaccines Market Forecast: Revenue ($ m), AGR (%), 2018-2030
Figure 5.11 Global Adult Vaccines Market Forecast: Revenues ($m) AGR (%), AGR (%), 2020-2030
Figure 5.12 Global Influenza Vaccines Market Forecast: Revenues ($m) AGR (%), AGR (%), 2020-2030
Figure 5.13 Global Therapeutic Vaccines Market Forecast: Revenues ($m) AGR (%), AGR (%), 2020-2030
Figure 6.1 World Vaccine Contract Manufacturing Market: Revenues ($ m) by Region, 2018
Figure 6.2 World Vaccine Contract Manufacturing Market: Revenues ($ m) by Region, 2019
Figure 6.3 Global Vaccine Contract Manufacturing Market Forecast: Revenue ($ m), AGR (%), 2018-2030
Figure 6.4 World Vaccine Contract Manufacturing Market: Market Shares (%) by Regional Market, 2019
Figure 6.5 World Vaccine Contract Manufacturing Market: Market Shares (%) by Regional Market, 2024
Figure 6.6 World Vaccine Contract Manufacturing Market: Market Shares (%) by Regional Market, 2030
Figure 7.1 North America Vaccine Contract Manufacturing Market Forecast: Revenue ($ m), AGR (%), 2018-2030
Figure 7.2 North America Vaccine Contract Manufacturing Market: Market Shares (%) by Regional Market, 2019
Figure 7.3 North America Vaccine Contract Manufacturing Market: Market Shares (%) by Regional Market, 2024
Figure 7.4 North America Vaccine Contract Manufacturing Market: Market Shares (%) by Regional Market, 2030
Figure 7.5 U.S. Vaccine Contract Manufacturing Market Forecast: Revenues ($ m), AGR (%), 2018-2030
Figure 7.6 Canada Vaccine Contract Manufacturing Market Forecast: Revenues($m), AGR (%), 2018-2030
Figure 8.1 Europe Vaccine Contract Manufacturing Market: Revenues ($m) by Country/Sub-region, 2019
Figure 8.2 Europe Vaccine Contract Manufacturing Market Forecast: Revenue ($ m), AGR (%), 2018-2030
Figure 8.3 Europe Vaccine Contract Manufacturing Market: Market Shares (%) by Country, 2018
Figure 8.4 Europe Vaccine Contract Manufacturing Market: Market Shares (%) by Country, 2024
Figure 8.5 Europe Vaccine Contract Manufacturing Market: Market Shares (%) by Country, 2030
Figure 8.6 Germany Vaccine Contract Manufacturing Market Forecast: Revenues ($ m), AGR (%), 2018-2030
Figure 8.7 France Vaccine Contract Manufacturing Market Forecast: Revenues ($m), AGR (%), 2018-2030
Figure 8.8 U.K. Vaccine Contract Manufacturing Market Forecast: Revenues ($ m), AGR (%), 2018-2030
Figure 8.9 Italy Vaccine Contract Manufacturing Market Forecast: Revenues ($m), AGR (%), 2018-2030
Figure 8.10 Spain Vaccine Contract Manufacturing Market Forecast: Revenues ($ m), AGR (%), 2018-2030
Figure 8.11 Rest of Europe Vaccine Contract Manufacturing Market Forecast: Revenues ($ m), AGR (%), 2018-2030
Figure 9.1 Asia Pacific Vaccine Contract Manufacturing Market: Revenues ($m) by Country/Sub-region, 2019
Figure 9.2 Asia Pacific Vaccine Contract Manufacturing Market Forecast: Revenue ($ m), AGR (%), 2018-2030
Figure 9.3 Asia Pacific Vaccine Contract Manufacturing Market: Market Shares (%) by Country, 2019
Figure 9.4 Asia Pacific Vaccine Contract Manufacturing Market: Market Shares (%) by Country, 2024
Figure 9.5 Asia Pacific Vaccine Contract Manufacturing Market: Market Shares (%) by Country, 2030
Figure 9.6 Japan Vaccine Contract Manufacturing Market Forecast: Revenues ($ m), AGR (%), 2018-2030
Figure 9.7 China Vaccine Contract Manufacturing Market Forecast: Revenues ($m), AGR (%), 2018-2030
Figure 9.8 India Vaccine Contract Manufacturing Market Forecast: Revenues ($ m), AGR (%), 2018-2030
Figure 9.9 Rest of Asia Pacific Vaccine Contract Manufacturing Market Forecast: Revenues ($m), AGR (%), 2018-2030
Figure 10.1 Latin America Vaccine Contract Manufacturing Market: Revenues ($m) by Country/Sub-region, 2019
Figure 10.2 Latin America Vaccine Contract Manufacturing Market Forecast: Revenue ($ m), AGR (%), 2018-2030
Figure 10.3 Latin America Vaccine Contract Manufacturing Market: Market Shares (%) by Country, 2019
Figure 10.4 Latin America Vaccine Contract Manufacturing Market: Market Shares (%) by Country, 2024
Figure 10.5 Latin America Vaccine Contract Manufacturing Market: Market Shares (%) by Country, 2030
Figure 10.6 Brazil Vaccine Contract Manufacturing Market Forecast: Revenues ($ m), AGR (%), 2018-2030
Figure 10.7 Mexico Vaccine Contract Manufacturing Market Forecast: Revenues ($m), AGR (%), 2018-2030
Figure 10.8 Rest of Latin America Vaccine Contract Manufacturing Market Forecast: Revenues ($m), AGR (%), 2018-2030
Figure 11.1 Middle East & Africa (MEA) Vaccine Contract Manufacturing Market: Revenues ($m) by Country/Sub-region, 2019
Figure 11.2 Middle East & Africa Vaccine Contract Manufacturing Market Forecast: Revenue ($ m), AGR (%), 2018-2030
Figure 11.3 Middle East & Africa Vaccine Contract Manufacturing Market: Market Shares (%) by Country, 2019
Figure 11.4 Middle East & Africa Vaccine Contract Manufacturing Market: Market Shares (%) by Country, 2024
Figure 11.5 Middle East & Africa Vaccine Contract Manufacturing Market: Market Shares (%) by Country, 2030
Figure 11.6 Saudi Arabia Vaccine Contract Manufacturing Market Forecast: Revenues ($ m), AGR (%), 2018-2030
Figure 11.7 South Africa Vaccine Contract Manufacturing Market Forecast: Revenues ($m), AGR (%), 2018-2030
Figure 11.8 Rest of Middle East & Africa Vaccine Contract Manufacturing Market Forecast: Revenues ($m), AGR (%), 2018-2030
Figure 12.1 : Lonza Revenue ($m), AGR (%), 2015-2019
Figure 12.2 Lonza: Business Segment Revenue Share (%), 2018
Figure 12.3 Pfizer, Inc.: Revenue ($m), AGR (%), 2014-2018
Figure 12.4 Pfizer, Inc.: Business Segment Revenue Share (%), 2018
Figure 12.5 Pfizer, Inc.: Region Revenue Share (%), 2018
Figure 12.6 Merck & Co, Inc.: Revenue ($m), AGR (%), 2015-2019
Figure 12.7 Merck & Co., Inc.: Business Segment Revenue Share (%), 2019
Figure 12.8 Merck & Co., Inc.: Region Revenue Share (%), 2019
Figure 12.9 AbbVie: Revenue ($m), AGR (%), 2015-2019
Figure 12.10 AbbVie: Business Segment Revenue Share (%), 2019
Figure 12.11 AbbVie: Region Revenue Share (%), 2019
Figure 12.12 Baxter: Revenue ($m), AGR (%), 2014-2018
Figure 12.13 Baxter: Business Segment Revenue Share (%), 2018
Figure 12.14 Baxter: Breakdown of Revenue (%) by Region, 2018
Figure 12.15 Catalent, Inc.: Revenue ($m), AGR (%), 2015-2019
Figure 12.16 Catalent, Inc.: Business Segment Revenue Share (%), 2019
Figure 12.17 Catalent, Inc.: Reporting Segment Revenue Share (%), 2019
Figure 12.18 Catalent, Inc.: Breakdown of Revenue (%) by Region, 2019
Figure 12.19 PRA Health Sciences, Inc.: Revenue ($m), AGR (%), 2015-2019
Figure 12.20 PRA Health Sciences, Inc.: Business Segment Revenue Share (%), 2019
Figure 12.21 PRA Health Sciences, Inc.: Breakdown of Revenue (%) by Region, 2019
Figure 12.22 Charles River Laboratories: Revenue ($m), AGR (%), 2015-2019
Figure 12.23 Charles River Laboratories: Business Segment Revenue Share (%), 2019
Figure 12.24 Charles River Laboratories: Breakdown of Revenue (%) by Region, 2019
Figure 12.25 Charles River Laboratories: Breakdown of Revenue (%) by Region, 2019
Figure 12.26 Boehringer Ingelheim: Revenue ($m), AGR (%), 2014-2018
Figure 12.27 Boehringer Ingelheim: Business Segment Revenue Share (%), 2019
Figure 12.28 Boehringer Ingelheim: Breakdown of Revenue (%) by Region, 2019
Figure 12.29 Meridian Life Science: Revenue ($m), AGR (%), 2015-2019
Figure 12.30 Meridian Life Science: Business Segment Revenue Share (%), 2019
Figure 12.31 Meridian Life Science: Breakdown of Revenue (%) by Region, 2019
Figure 14.1 Vaccine Contact Manufacturing Market: Comparison of Revenue ($m Forecasts for Total Market* and Market for Vaccine Contract Manufacturing Indication, 2018-2030
Figure 14.2 Global Vaccine Contract Manufacturing Market Forecast: Revenue ($m) 2018, 2024, and 2030
Figure 14.3 Global Vaccine Contract Manufacturing Market by Vaccine Type: Market Share (%), 2018
Figure 14.4 Global Vaccine Contract Manufacturing Market by Vaccine Type: Market Share (%), 2024
Figure 14.5 Global Vaccine Contract Manufacturing Market by Vaccine Type: Market Share (%), 2030
Figure 14.6 The Global Vaccine Contract Manufacturing Market Forecast by Region: Revenue (US$m), 2018, 2024, and 2030
List of Tables
Table 2.1 Timeline of Key Events in Vaccine Development, c.1000 AD – Present
Table 3.1 Vaccine Contract Manufacturing Market by Vaccine Type, 2020
Table 3.2 Global Vaccine Contract Manufacturing Market Forecast: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
Table 3.3 Global Vaccine Contract Manufacturing Market Forecast: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
Table 3.4 Global Vaccine Contract Manufacturing Market by Vaccine Type: CAGR (%), 2020-2024, 2024-2030, 2020-2030
Table 3.5 Global Attenuated Vaccine Market: Revenue* ($m), AGR (%) and CAGR (%), 2018-2030
Table 3.6 Global Inactivated Vaccine Market Forecast: Revenues ($m) AGR (%), AGR (%), 2020-2030
Table 3.7 Global Fluoroquinolones Market Forecast: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
Table 3.8 Global Subunit Vaccines Market Forecast: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
Table 3.9 Global Toxoid Vaccines Market Forecast: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
Table 3.10 Global Others Market Forecast: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
Table 4.1 Vaccine Contract Manufacturing Market by Workflow, 2020
Table 4.2 Global Vaccine Contract Manufacturing Market Forecast: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
Table 4.3 Global Vaccine Contract Manufacturing Market by Workflow: CAGR (%), 2020-2024, 2024-2030, 2020-2030
Table 4.4 Global Vaccine Contract Manufacturing (Downstream Processing) Market Forecast: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
Table 4.5 Global Fill & Finish Operations Market Forecast: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
Table 4.6 Global Analytical & QC studies Market Forecast: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
Table 4.7 Global Packaging Market Forecast: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
Table 4.8 Global Vaccine Contract Manufacturing (Upstream Processing) Market Forecast: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
Table 4.9 Global Mammalian Expression Systems Market Forecast: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
Table 4.10 Global Bacterial Expression Systems Market Forecast: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
Table 4.11 Global Yeast Expression Systems Market Forecast: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
Table 4.12 Global Baculovirus/Insect Expression Systems Market Forecast: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
Table 4.13 Global Others Market Forecast: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
Table 5.1 Vaccine Contract Manufacturing Market by Application, 2020
Table 5.2 Global Vaccine Contract Manufacturing Market Forecast: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
Table 5.3 Global Vaccine Contract Manufacturing Market by Application: CAGR (%), 2020-2024, 2024-2030, 2020-2030
Table 5.4 Global Paediatric Vaccines Market: Revenue* ($m), AGR (%) and CAGR (%), 2018-2030
Table 5.5 Global Adult Vaccines Market Forecast: Revenues ($m) AGR (%), AGR (%), 2020-2030
Table 5.6 Global Influenza Vaccines Market Forecast: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
Table 5.7 Global Therapeutic Vaccines Market Forecast: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
Table 6.1 Global Vaccine Contract Manufacturing Market by Region: Revenue ($ m), 2018 and 2019
Table 6.2 Global Vaccine Contract Manufacturing Market Forecast: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
Table 6.3 Global Vaccine Contract Manufacturing Market by Region: CAGR (%), 2020-2024, 2024-2030, 2020-2030
Table 6.4 Global Vaccine Contract Manufacturing Market by Region: Market Share (%), 2019, 2024, 2030
Table 7.1 North America Vaccine Contract Manufacturing Market Forecast, By Vaccine Type: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
Table 7.2 North America Vaccine Contract Manufacturing Market Forecast, By Workflow: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
Table 7.3 North America Vaccine Contract Manufacturing Market Forecast, By Workflow (Downstream Processing): Revenues ($ m), AGR (%), CAGR (%), 2018-2030
Table 7.4 North America Vaccine Contract Manufacturing (Upstream Processing) Market Forecast: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
Table 7.5 North America Vaccine Contract Manufacturing Market Forecast, By Application: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
Table 7.6 North America Vaccine Contract Manufacturing Market Forecast, By Class: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
Table 7.7 U.S. Vaccine Contract Manufacturing Market Forecast, By Country: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
Table 7.8 Canada Vaccine Contract Manufacturing Market Forecast: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
Table 8.1 Europe Vaccine Contract Manufacturing Market by Country/Sub-region: Revenue ($ m) and Market Share (%), 2019
Table 8.2 Europe Vaccine Contract Manufacturing Market Forecast, By Vaccine Type: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
Table 8.3 Europe Vaccine Contract Manufacturing Market Forecast, By Workflow: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
Table 8.4 Europe Vaccine Contract Manufacturing Market Forecast, By Workflow (Downstream Processing): Revenues ($ m), AGR (%), CAGR (%), 2018-2030
Table 8.5 Europe Vaccine Contract Manufacturing (Upstream Processing) Market Forecast: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
Table 8.6 Europe Vaccine Contract Manufacturing Market Forecast, By Application: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
Table 8.7 Global Vaccine Contract Manufacturing Market Forecast: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
Table 8.8 Global Vaccine Contract Manufacturing Market by Region: CAGR (%), 2020-2024, 2024-2030, 2020-2030
Table 8.9 Germany Vaccine Contract Manufacturing Market Forecast, By Country: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
Table 8.10 France Vaccine Contract Manufacturing Market Forecast: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
Table 8.11 U.K. Vaccine Contract Manufacturing Market Forecast, By Country: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
Table 8.12 Italy Vaccine Contract Manufacturing Market Forecast: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
Table 8.13 Spain Vaccine Contract Manufacturing Market Forecast, By Country: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
Table 8.14 Rest of Europe Vaccine Contract Manufacturing Market Forecast, By Country: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
Table 9.1 Global Vaccine Contract Manufacturing Market by Country/Sub-region: Revenue ($ m) and Market Share (%), 2019
Table 9.2 Asia Pacific Vaccine Contract Manufacturing Market Forecast, By Vaccine Type: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
Table 9.3 Asia Pacific Vaccine Contract Manufacturing Market Forecast, By Workflow: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
Table 9.4 Asia Pacific Vaccine Contract Manufacturing Market Forecast, By Workflow (Downstream Processing): Revenues ($ m), AGR (%), CAGR (%), 2018-2030
Table 9.5 Asia Pacific Vaccine Contract Manufacturing (Upstream Processing) Market Forecast: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
Table 9.6 Asia Pacific Vaccine Contract Manufacturing Market Forecast, By Application: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
Table 9.7 Asia-Pacific Vaccine Contract Manufacturing Market Forecast by Country: Revenues ($m), AGR (%), CAGR (%), 2018-2030
Table 9.8 Japan Vaccine Contract Manufacturing Market Forecast, By Country: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
Table 9.9 China Vaccine Contract Manufacturing Market Forecast: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
Table 9.10 India Vaccine Contract Manufacturing Market Forecast, By Country: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
Table 9.11 Rest of Asia Pacific Vaccine Contract Manufacturing Market Forecast: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
Table 10.1 Latin America Vaccine Contract Manufacturing Market by Country/Sub-region: Revenue ($ m) and Market Share (%), 2019
Table 10.2 Latin America Vaccine Contract Manufacturing Market Forecast, By Vaccine Type: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
Table 10.3 Latin America Vaccine Contract Manufacturing Market Forecast, By Workflow: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
Table 10.4 Latin America Vaccine Contract Manufacturing Market Forecast, By Workflow (Downstream Processing): Revenues ($ m), AGR (%), CAGR (%), 2018-2030
Table 10.5 Latin America Vaccine Contract Manufacturing (Upstream Processing) Market Forecast: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
Table 10.6 Latin America Vaccine Contract Manufacturing Market Forecast, By Application: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
Table 10.7 Latin America Vaccine Contract Manufacturing Market Forecast by Country: Revenues ($m), AGR (%), CAGR (%), 2018-2030
Table 10.8 Brazil Vaccine Contract Manufacturing Market Forecast, By Country: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
Table 10.9 Mexico Vaccine Contract Manufacturing Market Forecast: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
Table 10.10 Rest of Latin America Vaccine Contract Manufacturing Market Forecast: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
Table 11.1 Middle East & Africa Vaccine Contract Manufacturing Market by Country/Sub-region: Revenue ($ m) and Market Share (%), 2018
Table 11.2 Middle East & Africa Vaccine Contract Manufacturing Market Forecast, By Vaccine Type: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
Table 11.3 Middle East & Africa Vaccine Contract Manufacturing Market Forecast, By Workflow: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
Table 11.4 Middle East & Africa Vaccine Contract Manufacturing Market Forecast, By Workflow (Downstream Processing): Revenues ($ m), AGR (%), CAGR (%), 2018-2030
Table 11.5 Middle East & Africa Vaccine Contract Manufacturing (Upstream Processing) Market Forecast: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
Table 11.6 Middle East & Africa Vaccine Contract Manufacturing Market Forecast, By Application: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
Table 11.7 Middle East & Africa Vaccine Contract Manufacturing Market Forecast by Country: Revenues ($m), AGR (%), CAGR (%), 2018-2030
Table 11.8 Saudi Arabia Vaccine Contract Manufacturing Market Forecast, By Country: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
Table 11.9 South Africa Vaccine Contract Manufacturing Market Forecast: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
Table 11.10 Rest of Middle East & Africa Vaccine Contract Manufacturing Market Forecast: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
Table 12.1. Lonza Group AG: Overview, 2020
Table 12.2 Lonza: Revenue ($m), AGR (%), 2015-2019
Table 12.3 Pfizer, Inc.: Overview, 2020
Table 12.4 Pfizer, Inc.: Revenue ($m), AGR (%), 2014-2018
Table 12.5 Merck & Co., Inc.: Overview, 2020
Table 12.6 Merck & Co, Inc.: Revenue ($m), AGR (%), 2015-2019
Table 12.7 AbbVie: Overview, 2020
Table 12.8 AbbVie: Revenue ($m), AGR (%), 2015-2019
Table 12.9. Baxter: Overview, 2020
Table 12.10 Baxter: Revenue ($m), AGR (%), 2014-2018
Table 12.11. Catalent, Inc.: Overview, 2020
Table 12.12 Catalent, Inc.: Revenue ($m), AGR (%), 2015-2019
Table 12.13. PRA Health Sciences, Inc.: Overview, 2020
Table 12.14 PRA Health Sciences, Inc.: Revenue ($m), AGR (%), 2015-2019
Table 12.15. KBI Biopharma, Inc.: Overview, 2020
Table 12.16. Charles River Laboratories.: Overview, 2020
Table 12.17 Charles River Laboratories: Revenue ($m), AGR (%), 2015-2019
Table 12.18. Boehringer Ingelheim: Overview, 2020
Table 12.19 Boehringer Ingelheim: Revenue ($m), AGR (%), 2014-2018
Table 12.20. IDT Biologika GmbH: Overview, 2020
Table 12.21. Meridian Life Science: Overview, 2020
Table 12.22 Meridian Life Science: Revenue ($m), AGR (%), 2015-2019
Table 13.1 SWOT Analysis of the Global Vaccine Contract Manufacturing Market, 2020-2030
Figure 13.2 Vaccine Contract Manufacturing Market Drivers & Restraints 2020-2030
Table 14.1 Global Vaccine Contract Manufacturing Market Forecast: Revenue ($m), and CAGR (%), 2018, 2024 and 2030
Table 14.2 Global Vaccine Contract Manufacturing Market by Vaccine Type: CAGR (%), 2018, 2024, 2030
Table 14.3 Global Vaccine Contract Manufacturing Market by Region: CAGR (%), 2018, 2024, 2030
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
